They’ll be part of a national phase 3 clinical trial to test the efficacy and safety of a monoclonal antibody drug for mild to moderate COVID-19.
Giving state-level regulators more discretion in approving hydropower facilities in the United States led to faster adoption of the clean technology, a USC researcher and colleague find.
Infants born to mothers infected by the virus that causes COVID-19 could suffer from developmental difficulties and accelerated aging down the line, USC research finds.
USC researchers catalog physical and mental issues that have been exacerbated by the coronavirus pandemic.
After eight years in the Navy, Brian Phan is a well-traveled vet with a knack for photography who plans to put his USC education to use as a physician assistant.
The drugmaker says its vaccine is more than 90% effective. How did they do it? What does that mean for other vaccines in development? USC experts weigh in.
Graduates from the USC Suzanne Dworak-Peck School of Social Work have found not only jobs but personal satisfaction working with service members and their families.
A $2.9 million grant to Eileen Crimmins of the USC Leonard Davis School of Gerontology supports multination research on how life circumstances influence gene expression and affect health.
Angelina Crittenden is already making a difference through the First Generation Student Leadership Program she helped create. Her long-term plan: becoming a medical examiner.
